K

KromaTiD™ Inc.

33 employees

KromaTiD focuses on advancing the knowledge of genetic abnormalities and diseases by developing molecular cytogenetics assays and reagents.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Editing Process Optimization
CRISPR Analysis
Cell Culture Services
DNA Mutation Detection
Gene Editing Off-Target Effects
Gene Editing Quality Control
Genetic Disease Screening
Undiagnosed Disease Discovery
Genetic Disease Diagnosis
Chromatid and Chromosome Paint Products
Chromosome Analysis
Developer Platform
Genetic Disease Discovery
Genetics
Medical
Custom DNA Probes
Biomedical Applications

Date founded

2007

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

K

KromaTiD™ Inc. raised $2M on April 28, 2021

Investors: BroadOak Capital Partners

K

KromaTiD™ Inc. raised undisclosed on August 13, 2019

Investors: First Capital Business Development, LLC.

FAQ